Find Balsalazide Disodium manufacturers, exporters & distributors on PharmaCompass

Balsalazide

Balsalazide

Synopsis, Chemistry

APIs // Active Pharmaceutical Ingredients

12 API Suppliers, 10 USDMF, 1 EU WC, 2 KDMF, 6 NDC API, 4 Listed Suppliers

PRICE INFORMATION

API Reference Price, API Exports, API Imports

INTERMEDIATES

1 Suppliers

1 Suppliers

DOSSIERs // Finished Dosage Formulations

17 Dossiers, 9 FDA Orange Book, 5 Europe, 2 Australia, 1 Listed Dossiers

DRUG PRODUCT COMPOSITION

CAPSULE;ORAL - 750MG, TABLET;ORAL - 1.1GM **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

CAPSULE;ORAL - 750MG
TABLET;ORAL - 1.1GM **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

RELATED EXCIPIENT COMPANIES

Suppliers, 12 Kerry, 10 Corel Pharma Chem, 7 Seppic, 7 BASF, 6 Microlex e.U, 6 Lonza Capsugel, 4 Ideal Cures Pvt Ltd, 4 Gangwal Chemicals, 4 ACG Worldwide, 4 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd, 4 Roquette, 3 Kima Chemical, 2 Shanghai Shenmei Pharmaceutical Technology Co., Ltd, 2 Vasa Pharmachem, 2 Qualicaps, 2 Prachin Chemical, 2 Sigachi Industries, 2 Gangwal Healthcare, 2 The Dow Chemical Company, 1 Qianhao Chemical (Hebei) Co., Ltd, 1 Ingredion Pharma Solutions, 1 Nanjing Well Pharmaceutical, 1 DFE Pharma, 1 Pharmatrans-Sanaq, 1 Finar

EXCIPIENTS BY APPLICATIONS

43 Coating Systems & Additives, 18 Controlled & Modified Release, 12 Lubricants & Glidants, 11 Fillers, Diluents & Binders, 10 Film Formers & Plasticizers, 10 Disintegrants & Superdisintegrants, 9 Empty Capsules, 5 Thickeners and Stabilizers, 5 Granulation, 4 Direct Compression, 4 Vegetarian Capsules, 4 API Stability Enhancers, 4 Taste Masking, 3 Emulsifying Agents, 3 Topical, 2 Coloring Agents, 2 Solubilizers, 1 Rheology Modifiers, 1 Chewable & Orodispersible Aids, 1 Parenteral, 1 Co-Processed Excipients

GLOBAL SALES INFORMATION

17 US Medicaid Prescriptions, 6 Finished Drug Prices

MARKET PLACE

6 APIs

6 APIs

PATENTS

8 US Patents

8 US Patents

ANALYTICAL SOLUTION(s)

1 BioAnalytical Methods, 1 USP Standards, 2 Other Ref. Standards

DIGITAL CONTENT

4 News

4 News

Product Search

API SUPPLIERS

API Suppliers

US DMFs Filed

CEP/COS Certifications

JDMFs Filed

Other Certificates

Other Suppliers

API REF. PRICE (USD / KG)

API Market Place

INTERMEDIATES

DOSSIERS // FDF

USA (Orange Book)

Europe

Canada

Australia

South Africa

Uploaded Dossiers

GLOBAL SALES (USD Million)

U.S. Medicaid

188.00

Annual Reports

FDF Market Place

EXCIPIENTS

PATENTS & EXCLUSIVITIES

USFDA Orange Book Patents

USFDA Exclusivities

DIGITAL CONTENT

Blog #PharmaFlow

News

REF STANDARD

EDQM

USP

Other Listed Suppliers

SERVICES

Also known as: Colazal, 213594-60-6, 82101-18-6, Balsalazide sodium, Colazide, Bx-661a

Molecular Formula

C₁₇H₁₃N₃Na₂O₆

Molecular Weight

401.28 g/mol

InChI Key

CKMOQBVBEGCJGW-UHFFFAOYSA-L

FDA UNII

15ASW03C9S

Balsalazide Disodium is the disodium salt form of balsalazide, an aminosalicylate and oral prodrug that is enzymatically cleaved in the colon to produce the anti-inflammatory agent mesalazine. Mesalazine acts locally on the mucosa of the colon where it diminishes inflammation by blocking the production of arachidonic acid metabolites, including leukotrienes, prostaglandins and hydroxyeicosatetraenoic acids, and other inflammatory agents. Balsalazide disodium is used to treat chronic inflammatory bowel disease.

1 2D Structure

Balsalazide

2 Identification

2.1 Computed Descriptors

2.1.1 IUPAC Name

disodium;3-[[4-[(3-carboxy-4-oxidophenyl)diazenyl]benzoyl]amino]propanoate

2.1.2 InChI

InChI=1S/C17H15N3O6.2Na/c21-14-6-5-12(9-13(14)17(25)26)20-19-11-3-1-10(2-4-11)16(24)18-8-7-15(22)23;;/h1-6,9,21H,7-8H2,(H,18,24)(H,22,23)(H,25,26);;/q;2*+1/p-2

2.1.3 InChI Key

CKMOQBVBEGCJGW-UHFFFAOYSA-L

2.1.4 Canonical SMILES

C1=CC(=CC=C1C(=O)NCCC(=O)[O-])N=NC2=CC(=C(C=C2)[O-])C(=O)O.[Na+].[Na+]

2.2 Other Identifiers

2.2.1 UNII

15ASW03C9S

2.3 Synonyms

2.3.1 MeSH Synonyms

1. 5-(carboxyethylcarbamoyl-4-phenylazo)salicylic Acid

2. Balsalazide

3. Balsalazine

4. Bx 661a

5. Bx661a

6. Colazal

7. Colazide

2.3.2 Depositor-Supplied Synonyms

1. Colazal

2. 213594-60-6

3. 82101-18-6

4. Balsalazide Sodium

5. Colazide

6. Bx-661a

7. Balsalazidedisodium

8. Balsalazide Disodium Anhydrous

9. 15asw03c9s

10. Balsalazide Disodium Salt Hydrate

11. Giazo

12. Disodium;3-[[4-[(3-carboxy-4-oxidophenyl)diazenyl]benzoyl]amino]propanoate

13. Balsalazine

14. Balsalazide Disodium [usan]

15. Bx 661a

16. Nsc-760046

17. Balzide

18. Balsalazide Disodium Salt

19. Unii-15asw03c9s

20. Schembl30360

21. Schembl3666408

22. Chembl1200760

23. Hms2097a22

24. Hms3264m06

25. Hms3714a22

26. Balsalazide Sodium [who-dd]

27. Akos015896484

28. Akos025294907

29. Ccg-213078

30. Benzoic Acid, 5-((4-(((2-carboxyethyl)amino)carbonyl)phenyl)azo)-2-hydroxy-, Disodium Salt

31. Disodium 5-((4-(((2-carboxyethyl)amino)carbonyl)phenyl)azo)-2-hydroxybenzoate

32. Disodium 3-[[4-[(2-carboxylatoethylamino)-oxomethyl]phenyl]hydrazinylidene]-6-oxo-1-cyclohexa-1,4-dienecarboxylate

33. Ft-0622551

34. Ft-0658348

35. Balsalazide Disodium Salt Anhydrous [mi]

36. A815288

37. J-014008

38. Q27251713

39. 5-[4-(2-carboxyethylcarbamoyl)phenylazo]salicylic Acid Disodium Salt

40. Sodium (e)-5-((4-((2-carboxylatoethyl)carbamoyl)phenyl)diazenyl)-2-hydroxybenzoate

41. Sodium(e)-5-((4-((2-carboxylatoethyl)carbamoyl)phenyl)diazenyl)-2-hydroxybenzoate

42. 5-[(1e)-[4-[[(2-carboxyethyl)amino]carbonyl]phenyl]azo]-2-hydroxybenzoic Acid Disodium Salt

43. Benzoic Acid, 5-((1e)-(4-(((2-carboxyethyl)amino)carbonyl)phenyl)azo)-2-hydroxy-, Disodium Salt

44. Benzoic Acid, 5-((1e)-2-(4-(((2-carboxyethyl)amino)carbonyl)phenyl)diazenyl)-2-hydroxy-, Sodium Salt (1:2)

45. Disodium 3-[[4-[(3-oxidanidyl-3-oxidanylidene-propyl)carbamoyl]phenyl]hydrazinylidene]-6-oxidanylidene-cyclohexa-1,4-diene-1-carboxylate

46. Disodium,(3z)-3-[[4-(2-carboxylatoethylcarbamoyl)phenyl]hydrazinylidene]-6-oxocyclohexa-1,4-diene-1-carboxylate

2.4 Create Date

2019-01-15

3 Chemical and Physical Properties

Molecular Formula	C₁₇H₁₃N₃Na₂O₆
Molecular Weight	401.28 g/mol
Hydrogen Bond Donor Count	2
Hydrogen Bond Acceptor Count	8
Rotatable Bond Count	6
Exact Mass	401.05997371 g/mol
Monoisotopic Mass	401.05997371 g/mol
Topological Polar Surface Area	154 Å²
Heavy Atom Count	28
Formal Charge	0
Complexity	539
Isotope Atom Count	0
Defined Atom Stereocenter Count	0
Undefined Atom Stereocenter Count	0
Defined Bond Stereocenter Count	0
Undefined Bond Stereocenter Count	0
Covalently Bonded Unit Count	3

4 Pharmacology and Biochemistry

4.1 MeSH Pharmacological Classification

Gastrointestinal Agents

Drugs used for their effects on the gastrointestinal system, as to control gastric acidity, regulate gastrointestinal motility and water flow, and improve digestion. (See all compounds classified as Gastrointestinal Agents.)

Anti-Inflammatory Agents, Non-Steroidal

Anti-inflammatory agents that are non-steroidal in nature. In addition to anti-inflammatory actions, they have analgesic, antipyretic, and platelet-inhibitory actions. They act by blocking the synthesis of prostaglandins by inhibiting cyclooxygenase, which converts arachidonic acid to cyclic endoperoxides, precursors of prostaglandins. Inhibition of prostaglandin synthesis accounts for their analgesic, antipyretic, and platelet-inhibitory actions; other mechanisms may contribute to their anti-inflammatory effects. (See all compounds classified as Anti-Inflammatory Agents, Non-Steroidal.)

4.2 FDA Pharmacological Classification

4.2.1 Pharmacological Classes

Aminosalicylic Acids [CS]; Aminosalicylate [EPC]